Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Koji Kawaguchi, Katsutsugu Umeda, Satoshi Miyamoto, Nao Yoshida, Hiromasa Yabe, Takashi Koike, Michiko Kajiwara, Hiroshi Kawaguchi, Yoshiyuki Takahashi, Masataka Ishimura, Hirotoshi Sakaguchi, Asahito Hama, Yuko Cho, Maho Sato, Keisuke Kato, Atsushi Sato, Koji Kato, Ken Tabuchi, Yoshiko Atsuta, Kohsuke Imai
Publikováno v:
Bone Marrow Transplantation. 58:600-602
Autor:
Haruka Mimatsu, Atsuto Onoda, Tomohiko Kazama, Koji Nishijima, Yoshie Shimoyama, Shoji Go, Kazuto Ueda, Yoshiyuki Takahashi, Taro Matsumoto, Masahiro Hayakawa, Yoshiaki Sato
Publikováno v:
Scientific Reports. 13
Neonatal necrotizing enterocolitis (NEC) is a serious disease of premature infants that necessitates intensive care and frequently results in life-threatening complications and high mortality. Dedifferentiated fat cells (DFATs) are mesenchymal stem c
Autor:
Asuka Kono, Manabu Wakamatsu, Yoshihiro Umezawa, Hideki Muramatsu, Hiroki Fujiwara, Dan Tomomasa, Kento Inoue, Keiichiro Hattori, Tetsuo Mitsui, Hidetoshi Takada, Yoshiyuki Minegishi, Yoshiyuki Takahashi, Masahide Yamamoto, Takehiko Mori, Hirokazu Kanegane
Publikováno v:
International Journal of Hematology.
Autor:
Atsuhiro Hirayama, Tadanobu Nagaya, Takuma Okamura, Takeji Umemura, Yoshiyuki Takahashi, Yugo Iwaya, Mai Iwaya, Takeshi Uehara
Publikováno v:
Digestive Diseases and Sciences. 68:451-459
Background Immune checkpoint inhibitors (ICPIs) have revolutionized cancer therapy, although immune-related adverse events (irAEs) remain a severe issue. The clinical characteristics of colitis induced by ICPIs are very similar to inflammatory bowel
Autor:
Moe Miyagishima, Motoharu Hamada, Yuji Hirayama, Hideki Muramatsu, Takahisa Tainaka, Chiyoe Shirota, Akinari Hinoki, Takahiro Imaizumi, Masahiro Nakatochi, Michi Kamei, Eri Nishikawa, Nozomu Kawashima, Atsushi Narita, Nobuhiro Nishio, Seiji Kojima, Yoshiyuki Takahashi
Publikováno v:
International Journal of Hematology. 116:288-294
ObjectiveCentral venous catheters (CVCs) have been essential devices for the treatment of children with hematological and oncological disorders. Only few studies investigated the complications and selections of different types of CVCs in these pediat
Autor:
Taro Fukuta, Hideki Muramatsu, Daiki Yamashita, Daichi Sajiki, Ryo Maemura, Yusuke Tsumura, Ayako Yamamori, Masayuki Imaya, Manabu Wakamatsu, Eri Nishikawa, Kotaro Narita, Shinsuke Kataoka, Rieko Taniguchi, Atsushi Narita, Nobuhiro Nishio, Yoshiyuki Takahashi
Publikováno v:
International Journal of Hematology.
Autor:
Motoharu Hamada, Hideki Muramatsu, Yuka Torii, Kyogo Suzuki, Atsushi Narita, Taro Yoshida, Masayuki Imaya, Ayako Yamamori, Manabu Wakamatsu, Shunsuke Miwata, Kotaro Narita, Shinsuke Kataoka, Nozomu Kawashima, Rieko Taniguchi, Eri Nishikawa, Nobuhiro Nishio, Yoshinori Ito, Seiji Kojima, Yoshiyuki Takahashi
Publikováno v:
International Journal of Hematology.
Autor:
Mahboba Jabary, Atsuto Onoda, Yuma Kitase, Kazuto Ueda, Haruka Mimatsu, Shoji Go, Ryosuke Miura, Masahiro Tsuji, Yoshiyuki Takahashi, Masahiro Hayakawa, Yoshiaki Sato
Publikováno v:
Scientific Reports. 13
Fetal growth restriction (FGR), followed by postnatal early catch-up growth, is associated with an increased risk of metabolic dysfunction, including type 2 diabetes in humans. This study aims to determine the effects of FGR and early catch-up growth
Autor:
Maho Sato, Tomohiro Morio, Hiromasa Yabe, Akira Nishimura, Koji Kato, Yoshiyuki Takahashi, Masami Inoue, Satoshi Miyamoto, Takashi Koike, Akihiro Iguchi, Kohsuke Imai, Tomonari Shigemura, Yoshiko Atsuta, Yoji Sasahara, Michiko Kajiwara, Masakatsu Yanagimachi, Motohiro Kato, Yoshiko Hashii, Mio Kurata, Masataka Ishimura, Katsutsugu Umeda
Publikováno v:
Journal of Clinical Immunology
Purpose Hematopoietic cell transplantation (HCT) is a curative therapy for patients with severe combined immunodeficiency (SCID). Here, we conducted a nationwide study to assess the outcome of SCID patients after HCT in Japan. Methods A cohort of 181
Autor:
Takahiro Imaizumi, Julia Meyer, Manabu Wakamatsu, Hironobu Kitazawa, Norihiro Murakami, Yusuke Okuno, Taro Yoshida, Daichi Sajiki, Asahito Hama, Seiji Kojima, Yoshiyuki Takahashi, Mignon Loh, Elliot Stieglitz, Hideki Muramatsu
Publikováno v:
Scientific reports, vol 12, iss 1
Juvenile myelomonocytic leukemia (JMML) is a rare heterogeneous hematological malignancy of early childhood characterized by causative RAS pathway mutations. Classifying patients with JMML using global DNA methylation profiles is useful for risk stra